Literature DB >> 31970320

Exercise therapy for muscle and lower motor neuron diseases.

Aisha Munawar Sheikh1, John Vissing1.   

Abstract

Muscle and lower motor neuron diseases share a common denominator of perturbed muscle function, most often related to wasting and weakness of muscles. This leads to a number of challenges, such as restricted mobility and respiratory difficulties. Currently there is no cure for these diseases. The purpose of this review is to present research that examines the effects of exercise in muscle and lower motor neuron diseases. Evidence indicates that moderate intensity aerobic- and strength exercise is advantageous for patients with muscle diseases, without causing harmful exercise-induced muscle damage. On the contrary, motor neuron diseases show a rather blunted response from exercise training. High-intensity training is a modality that seems safe and a promising exercise method, which may circumvent neural fatigue and provide effect to patients with motor neuron disease. Although we have come far in changing the view on exercise therapy in neuromuscular diseases to a positive one, much knowledge is still needed on what dose of time, intensity and duration should be implemented for different disease and how we should provide exercise therapy to very weak, non-ambulatory and wheelchair bound patients. ©2019 Gaetano Conte Academy - Mediterranean Society of Myology, Naples, Italy.

Entities:  

Keywords:  exercise; motor neuron disease; muscle disease

Mesh:

Year:  2019        PMID: 31970320      PMCID: PMC6955630     

Source DB:  PubMed          Journal:  Acta Myol        ISSN: 1128-2460


Background

Muscle and lower motor neuron diseases encompass a large number of conditions with a common denominator of muscle weakness and wasting in most cases, which may lead to a number of challenges, such as fatigue, restricted mobility, and respiratory difficulties that impact a person’s quality of life (1). Currently, treatment options for these diseases are scarce, and patients rely on supportive disease management that may contribute to enhance quality of life by improving physical function and possibly stabilizing or slowing down disease progression. For a long time, physical exercise was considered deleterious for patients with muscle diseases, the notion being that contractions in the pathological muscle would accelerate the disease process. This notion was supported by experiments in the mdx mouse model of Duchenne muscular dystrophy that showed signs of damage after exercise. However, the types of exercise used were highly unphysiological as they involved eccentric exercise and electrical stimulation of muscle (2, 3) types of exercise that would also induce muscle damage in a healthy individual. Exercise is physical activity that is planned, structured, and repetitive for the purpose of conditioning any part of the body. The general population is encouraged to exercise because of its great health benefits, and it’s importance as a means of physical rehabilitation is also widely acknowledged (4). Lack of exercise, regardless of condition, leads to a variety of changes in the body. The heart’s ability to pump blood efficiently, aerobic capacity, and muscles’ capacity to process oxygen declines, which ultimately leads to decreased endurance, muscle weakness, and fatigue (4), as well as numerous lifestyle-related diseases. Patients with muscle and lower motor neuron diseases are more prone to developing disorders associated with a sedentary lifestyle, such as obesity and metabolic syndrome due to restricted mobility (5-7). Currently there are no specific guidelines about the type or intensity of exercise recommended to these patients. One of the challenges health care professionals often face is the question of how much, and what type of exercise should patients engage in. Nonetheless, the body of evidence favoring exercise training in patients with muscle and lower motor neuron diseases has increased substantially in the last two decades, and the purpose of this review is to present the current evidence for physical conditioning in these disease groups.

Methods

A literature search on PubMed, using key words “Limb girdle muscular dystrophy”, “Becker muscular dystrophy”, “facioscapulohumeral muscular dystrophy”, “myotonic muscular dystrophy”, “McArdle disease”, “Pompe disease”, “mitochondrial myopathy”, “spinal and bulbar muscular atrophy”, “spinal muscular atrophy” combined with key words “exercise”, “training”, “physical activity”, “resistance training”, “resistance exercise”, “strength training”, “strength exercise”, “aerobic training”, “aerobic exercise”, “endurance training”, “endurance exercise”, was performed from January 2018 to July 2019. Article selection was based on 1) studies assessing the effects of exercise on humans with these diseases, 2) articles that included a well described diagnosis of a muscle or motor neuron disease, and 3) articles that provided a well-described exercise intervention. We included randomized controlled trials (RCT), cohorts, and case reports. Articles were excluded if they did not include an exercise intervention, lacked intervention description, or were animal studies. In addition, articles exclusively focusing on training of respiratory muscles were also excluded. Using these inclusion and exclusion criteria’s, fifty articles were chosen to form the basis for this review.

Experience with exercise training in individuals with muscle and lower motor neuron diseases

Muscular dystrophies

Limb girdle muscular dystrophy

Aerobic exercise

More than 32 different kinds of Limb girdle muscular dystrophies (LGMD) are known, and exercise has only been studied in a few of the disorders. Aerobic exercise has been studied in smaller cohorts of LGMD2I and LGMD2L. Patients with LGMD2L completed a 10-week moderate aerobic training program (8). The six patients completing the training experienced improvements in fitness, functional capacity, and lower limb strength. No adverse events were reported. Moderate endurance training also improved aerobic capacity in 9 patients with LGMD2I (9), and patients expressed feeling an improvement in physical function. There was no significant increase in training-induced creatine kinase (CK) levels. Moderate aerobic training seems to provide patients with LGMD better physical function and appears safe, but longer-term studies are needed.

Strength exercise

Low- and high-intensity resistance training in patients with LGMD2A and LGMD2I was found to be generally well tolerated (10). Two LGMD2A patients were excluded from the high resistance training group due to training-induced CK elevation. Resistance training could potentially be a beneficial part of a functional rehabilitation program, but should be carefully monitored for muscle damage.

Assisted exercise

Sczesny-Kaiser et al. (11) performed a treadmill exercise study using hybrid assistive limb (HAL®) in three LGMD patients; LGMD2A, LGMD2I, and a LGMD of unknown subtype. HAL® is a powered exoskeleton and is used during exercise to enhance physical capabilities in people with disabilities. Physical endurance improved and no adverse events were reported. Despite a small sample size, the results are interesting, and the technology allows health care professionals to train very weak patients. Anti-gravity training improved functional ability in weak patients with LGMD2I (12), and enhanced lower limb strength and walking distance (13). Both studies were safe and well tolerated and plasma CK levels did not indicate any exercise-induced muscle damage. Bodyweight-supported training allows patients to work at a certain percentage of bodyweight due to off-lifting of weight by slings or air pressure making it possible for weak patients to exercise. However, it is costly and cannot be performed in patients’ habitual environment.

Other exercise modalities

Effect of electrical stimulation therapy and exercise therapy in patients with LGMD was investigated by Kılınç et al. (14). In the electrical stimulation therapy group, stimulation was applied bilaterally on the deltoid and quadriceps muscles using high voltage-pulsed galvanic stimulation with a pulse frequency of 50Hz for optimal contractions. Duty cycle was set at 5 seconds on and 10 seconds off, during 10 minutes of stimulation of each muscle. The exercise therapy group consisted of bilateral progressive resistance exercise of the deltoid and quadriceps muscles. The electrical stimulation therapy group gained muscle strength and physical function improved. The exercise therapy group had similar improvements. This study provides important information on the role of electrical stimulation therapy and exercise therapy for health care professionals working in rehabilitation clinics. Intervention specifications for LGMDs are presented in Table 1.
Table 1.

A representation of exercise interventions done in LGMD 2A, LGMD 2L, and LGMD 2I. Number in parenthesis represents the article reference.

Exercise mode/NDurationFrequencyIntensityImproved outcome
CyclingN = 6(8)10 weeks3 days/week30 min/session70% of VO2maxVO2max, lower limb strength, 6MWT, 5 x STS, 6SST.
CyclingN = 9(9)12 weeks50 sessions in total30 min/session65% of VO2maxVO2max, workload, self-reported physical endurance, lower limb muscle strength, and walking distance.
Strength:LOITN = 6HITN = 3Control groupN = 6(10)6 months3 months3 days/weekTwice at home and once at lab3 days/week at labLow intensityKnee extension, Elbow flexion40% of 1RM, increase with 5% every other week3 sets x 12-15 repsHigh intensity:Knee extension, Elbow flexionWrist flexion & extensionAnkle plantar flexion70-85% of 1RM 3 x 8-12 reps for 1 month80-90% of 1RM 3 x 6-10 reps for 2 months85-92% 3 x 8-4 reps for 3 monthsBicep strength and endurance, wrist flexion, extension, and endurance
Treadmill training using HAL®N = 3(11)8 weeksF/U at 6 weeks post intervention3 days/weekMaximum of 30 minutes/sessionVelocity of treadmill was set individuallyUp to 50% body weight support10MWT, 6MWT, and TUG
Anti-gravity:N = 3(12)10 weeks of control period10 weeks of training3 days/week40 min/session70-80% of maximum heart rate (HRmax)Run/walk, jogging, and high knee lift12 reps of squats and lunges15-20 reps of calf raise6MWT and dynamic balance
Bodyweight supported:N = 3(13)10-week control period10 weeks of training3 days/week40 min/session70-80% of HRmaxClosed-kinetic-chain strength exercises: squats, calf raises, and lungesAerobic:Walk/run, joggingin place, or high knee-liftClosed kinetic chain leg strength and training distance
ElectricalstimulationN = 11StrengthN = 13(14)8 weeks3 days/weekShoulder abductionKnee extension25% 1RM, 2 sets x10 reps30% 1RM, 3 sets x 10 reps35% 1RM, 3 sets x 10 reps50% 1RM, 3 sets x 10 repsMonophasic wave type. Surface electrodes. Pulse frequency 50Hz, voltage output 0-500 V, pulse duration 200μσ, duty cycle 5:10, 10 minutes of stimulationStrength, VAS, climb 8 steps, 10MWT, dressing with t-shirt, endurance (number of reps per minute), and modified Lawton ADL.

Becker muscular dystrophy

Moderate cycle training improves aerobic capacity and strength in patients with Becker muscular dystrophy (BMD) after three months of exercise, and these improvements are maintained after additional 9 months of training, without any rise in CK level (15). Enhancement in muscle strength and physical function after treadmill training were also reported in a case study (16). Interestingly, an elevation in CK level was observed, indicating that rehabilitative intervention should be carefully monitored to avoid harmful exercise-induced side effects despite functional improvement. In patients with BMD, low- and high-intensity resistance training was generally well tolerated and patients showed an increase in endurance and arm strength (10), without signs of muscle damage. Anti-gravity training resulted in improved physical function and functional ability (12), and another study found that bodyweight-supported training improved lower limb strength and walking distance (13). In both studies, exercise was well tolerated and CK levels did not indicate any exercise-induced muscle damage. Intervention specifications for BMD are presented in Table 2.
Table 2.

A representation of exercise interventions done in BMD. Number in parenthesis represents the article reference.

Exercise mode/NDurationFrequencyIntensityImproved outcome
CyclingN = 11Control groupN = 7(15)12 weeks12 months F/U50 sessions in total30 min/session65% of VO2maxVO2max, workload, hip abduction, and ankle plantar flexion and dorsiflexion
TreadmillN = 1(16)4 weeks3 days/week20 min/session65-80% HRmaxLower limb strength, TUG, 10MWT, and 6MWT
Strength:LOITN = 2HITN = 1Control groupN = 6(10)6 months3 monthsLOIT3 days/weekTwice at home and once at labHIT3 days/week at labLow intensity:Knee extension, Elbow flexion40% of 1RM, increase with 5% every other week3 sets x 12-15 repsHigh intensity:Knee extension, Elbow flexionWrist flexion & extensionAnkle plantar flexion70-85% of 1RM 3 sets x 8-12 reps, month 180-90% of 1RM 3 sets x 6-10 reps, month 285-92% 3 sets x 8-4 reps, month 3Bicep strength and endurance, wrist flexion, extension, and endurance
Anti-gravity:N = 5(12)10 weeks of control period10 weeks of training intervention3 days/week40 min/session70-80% of maximum heart rate (HRmax) Run/walk, jogging, and high knee lift12 reps of squats and lunges15-20 reps of calf raise6MWT and dynamic balance
Bodyweight supported:N = 5(13)10 weeks control period10 weeks of training intervention3 days/week40 min/session70-80% of HRmaxClosed-kinetic-chain strength exercises: squats, calf raises, and lungesAerobic:Walk/run, joggingin place, or high knee-liftClosed kinetic chain leg strength and training distance

Facioscapulohumeral muscular dystrophy

Moderate aerobic exercise improved self-reported changes in activities of daily living (ADL) in a cohort of 8 patients with facioscapulohumeral muscular dystrophy (FSHD) (17). Similar improvements were discovered in a randomized, double-blind, placebo-controlled parallel study where the investigators found improvements in fitness, self-assessed physical capacity, and health (18). Voet et al examined the effects of moderate aerobic exercise therapy and cognitive behavioral therapy on fatigue, strength, and exercise tolerance. One group underwent cycling and one group underwent cognitive behavioral therapy comprising of 6 modules directed towards insufficient coping with the disease. After a 12-week follow-up, the majority of patients continued their level of activity and the beneficial effects remained (19). This study provides valuable information about the impact of physical activity on fatigue. Fatigue can have a detrimental effect on quality of life, and it is substantial to apply appropriate management. Safety and efficacy of a 6-month home-based exercise program was assessed in a multicenter randomized controlled trial (20). The results showed an improvement in aerobic capacity, strength, and functional capacity. Exercise did not elevate CK levels in any of the presented studies. Health care professionals are encouraged to promote regular exercise compatible with FSHD patients’ daily professional and social life. Strength training in patients with FSHD was examined by van der Kooi et al in a randomized, double-blind, placebo-controlled trial (21). Training group consisted of 34 patients and a non-training control group consisted of 31 patients. At week 26 during the intervention, albuterol was added. Some improvements in strength were observed in the training group and any training-induced muscle fatigue that occurred lasted less than an hour, and patients were able to carry out their habitual ADL. Of the 34 trained patients, 19 patients complained of neck and shoulder pain after the intervention. Plasma CK levels were not reported. The authors determined the training to be generally well tolerated and found no enhancing effects of albuterol. The number of patients reporting pain in neck and shoulder is great and the tolerability to strength training should be explored further. Andersen et al. (22) investigated the effects of supervised high-intensity training (HIT) in an RCT. Fitness improved and CK measurements did not indicate any muscle damage during and post training. The majority of patients preferred HIT over moderate-intensity training. High-intensity training may be a good option for patients struggling with fatigue. Neuromuscular electrical stimulation (NMES) is passive muscular training that can easily be adapted in the clinic and may be advantageous for very weak patients. Colson et al. (23) studied the safety and efficacy of NMES and found that the treatment was safe and well tolerated. Patients reported a reduction in pain, fatigue, and an increase in functional capacity and strength. In addition, patients expressed feeling a positive effect on ADL. There was no significant CK level elevation during the intervention. Intervention specifications for FSHD are presented in Table 3.
Table 3.

A representation of exercise interventions done in FSHD. Number in parenthesis represents the article reference.

Exercise mode/NDurationFrequencyIntensityImproved outcome
CyclingN = 8Control groupN = 7(17)12 weeks5 days/week35 min/session65% VO2maxVO2max, workload, and ADL
Cycling + post exercise protein-carbohydrate supplementN = 18Cycling + placebo supplementN = 13Control groupN = 10(18)12 weeks12 months F/U3 days/week15 min/session week 120 min/session week 230 min/session from week 370% VO2max6MWT, workload, fitness, and SF-36
CyclingN = 20Cognitive-behavioral therapyN = 13Usual careN = 24(19)16 weeks3 days/week (2 days at home and 1 day supervised)38 min/session, including a 5 min warm up 30 min exercise 3 min cool downCognitive-behavioral therapy comprised of 6 modules:Dysfunctional cognitions regarding fatigue, activity, pain, or other symptoms; fatigue catastrophizing (a cognitive process that involves negative outcome expectations from fatigue); dysregulation of sleep or activity; poor social support; and negative social interactions. Both aerobic exercise therapy and cognitive behavioral therapy were found to be superior to usual care in reducing fatigue50-65% HRmax12-14 RPE (Borg Scale)Fatigue
CyclingN = 8Control groupN = 8(20)24 weeks3 days/week35 min/session2 sessions at 60% max aerobic power1 session interval training 40% and 80% max aerobic powerVO2max, 6MWT, and fatigue severity scale
StrengthN = 34ControlN = 31(21)52 weeks3 days/week10 RM, 2 sets x 5-10 reps Dynamic and isometric strength:Elbow flexion and ankle dorsal flexion1RM, and dynamic elbow flexor strength
HIT:CyclingN = 6UCN = 7Control groupN = 7(22)8 weeks supervised8 weeks with unsupervised for all.21 min/session, including an 8-min warm-up and two sets of5-min HIT with 3-min break at very low intensity.3 days/weekEach minute of HIT was performed at threedifferent work intensities: 30 s of easy pedaling (lowintensity), 20 s of hard work (middle high intensity), and10 s of all-out, maximal intensityVO2max and workload
NMESN = 9(23)5 months5 days/week20 min/sessionRise time 1.5s; steady tetanic stimulationtime: 6s; fall time 1.5sPain, fatigue, shoulder flexion strength, knee extension strength, and 6MWT

Myotonic muscular dystrophy

Ørngreen et al. (24) studied the effects of aerobic training. Twelve of the 17 patients completed the study, five patients discontinued due to low compliance, and nine adhered adequately to the training protocol. Most patients reported beneficial changes in ADL and fitness improved after the training. Plasma CK levels did not increase, but one patient reported a worsening of fatigue. The effect of strength training was first reported in 1993, where modest strength improvements were observed after 12 weeks of exercise (25). Tollbäck et al. (26) also found improvements in strength after training for 12 weeks. Two patients dropped out for personal reasons and one dropped out due to severe back pain. No other adverse events were reported by the authors in the two studies. A study reported in 1995(27) and another in 1999(28) that strength training was safe and well tolerated, but no apparent improvements were observed, neither any adverse events nor deterioration was reported. The absence of any prominent changes differs from previous studies (25, 26). One explanation could be that the patients exercised at home, which may influence the validity of their reporting and compliance or the effect of exercise was assessed with unfitting outcome measures. Cudia et al investigated the effects of functional electrical stimulation induced cycling (29) and compared the intervention with strength and aerobic training. Muscle strength and walking distance improved. Improvements were also observed in the strength and aerobic group and no adverse events were reported. Fatigue can limit everyday activities and adherence to exercise in these patients, and a reduction in treatment time, could possibly improve patient compliance. Patients with myotonic muscular dystrophy (DM) often face challenges with impaired hand function. Aldehag et al. (30) investigated the effects of hand training with a silicone-based resistance putty in a randomized controlled crossover pilot study. Patients improved hand strength and self-perception of occupational performance. Despite a large dropout due to personal reasons, lack of motivation, and fatigue, the study addresses an important issue that hand impairment can have on ADL. Recently, Okkersen et al assessed the effects of cognitive behavioral therapy with optional graded exercise therapy in patients with severe fatigue in a single-blind, large randomized trial (31). Cognitive behavioral therapy increased patients’ capacity for activity and participation, compared with standard care alone. Intervention specifications for DM are presented in Table 4.
Table 4.

A representation of exercise interventions done in DM. Number in parenthesis represents the article reference.

Exercise mode/NDurationFrequencyIntensityImprovedoutcome
CyclingN = 9(24)12 weeks5 days/week35 min/session65% of VO2maxSelf-reported improvements in ADL, VO2max, and workload
StrengthN = 27Control groupN =14(25)12 weeks3 days/weekKnee extension: 30-40% of max, 3 sets x 4-8 repsElbow flexion 10-20% of max, 3 sets x 4-8 repsHand grip: 100%, 3 sets x 4 repsIncrease in strength
StrengthN = 6(26)12 weeks3 days/weekKnee extension60-80% of 1RM, 3 x 10 reps1RM
StrengthN = 33(27)24 weeks3 days/week30 min/sessionKnee extension and flexion, hip extension and abduction60-80% of 1RMWeek 1-8: 60% of 1RM, 3 sets x 25 repsWeek 9-16: 70% of 1RM, 3 sets x 15 repsWeek 17-24: 80% of 1RM, 3 sets x 10 repsNeither positive or negative effects of the training
StrengthN = 33(28)24 weeks3 days/weekKnee extension and flexion, hip extension and abduction60-80% of 1RMWeek 1-8: 60% of 1RM, 3 sets x 25 repsWeek 9-16: 70% of 1RM, 3 sets x 15 repsWeek 17-24: 80% of 1RM, 3 sets x 10 repsNeither positive or negative effects of the training
Functional electrical stimulation induced cyclingN = 4Strength and cyclingN = 4(29)3 weeks6 weeksFunctional electrical stimulation:30 minutes5 days/weekStrength:5 days/week30 min/sessionCycling:5days/week30 min/sessionFunctional electrical stimulation:Frequency of 30 Hz (pulse width, 200 μseconds)Strength training:Knee extension, knee flexion, ankle dorsiflexion, ankle plantarflexion2 sets x 10 reps at 60% of 1RM (week 1-3)2 sets x 5 reps at 80% of 1RM (week 4-6)Cycling:60% of HRmaxMRC, 6MWT and 10MWT
Hand-trainingCross-over studyN = 9 Group AN = 4 Group B(30)12 weeks of training12 weeks of wash out12 weeks of controlMinimum of 27 sessions60 min/sessionWeek 1-4: 1 set x 10 repsWeek 5-8: 2 sets x 10 repsWeek 9-12: 3 sets x 10 repsIsolated finger movement:1 set x 3 reps, 2 sets x 3 reps, 3 sets x 3 repsWrist extension/flexionFinger extension/flexionIsolated finger extension/flexionThumb extension/flexionFinger adduction/abductionStretching wrist in flexion/flexionHandgrip, pinch, and wrist strength

Glycogen storage disease

McArdle disease

Haller et al. (32) found that patients generally benefitted from moderate aerobic training. However, one patient had elevated CK levels the first two weeks of intervention, which stabilized thereafter, and another patient had elevated CK levels during week 8, possibly due to unusual physical exertion at home, according to author reporting. Aside from the two patients, CK levels remained stable, indicating that exercise did not provoke muscle injury. Porcelli et al. (33) found that home-based aerobic training also increased fitness in patients with McArdle disease. However, patients did not feel any benefits from the exercise nor did the intervention increase their habitual ADL. Maté-Munoz et al. (34) examined the acute and chronic responses to exercise in patients with McArdle disease. The acute response consisted of two tests (see Table 5). Ten patients underwent an 8-month long supervised moderate aerobic exercise program to test the chronic exercise response. Most patients chose walking as preferred exercise mode. Both the acute and chronic group showed an increase in fitness and ventilatory threshold. No adverse events or discomfort were reported and CK levels remained stable post exercise.
Table 5.

A representation of exercise interventions done in McArdle disease. Number in parenthesis represents the article reference.

Exercise mode/NDurationFrequencyIntensityImproved outcome
CyclingN = 8(32)14 weeksWeek 1-7:4 days/week30 min/sessionWeek 8-14:4 days/week40 min/session60-70% HRmaxOxidative and work capacity
Electromagnetically braked cyclingN = 7(33)12 weeks4 days/week60-90 min/session65-70% of HRmaxAerobic capacity and work load
Acute:Cycling(strictly monitored)N = 46Control groupN = 46Chronic:Walking or cyclingN = 9(34)Acute:1 dayChronic:8 months1 day5 days/week60 min/session1. Workload increased with 10 Watt/min until exhaustion, starting at 10 Watt2. A 12-minute constant-load test at the power output reaching ventilatory threshold on a cycleThe two tests were separated by a 10-minute active rest period (freewheel pedaling)75 g sucrose beverage prior to test60% of HRmaxComplex carbs 1 hour before exercise and simple carbs during exerciseAerobic capacity, peak power output, and ventilatory threshold
StrengthN = 1(35)6 weeks2 days/weekUp to 60 min/session65-70% of 1RM10-minute warm-up consisting of 5 minutes of light-intensity dynamic exercise (on a cycle ergometer or rowing ergometer), followed by 5 minutes of mobilization exercisesand body weight exercises (eg, shoulder shrugs and rotations, arm elevations, changing squat stance, walkinglunges, push-ups on the wall).Benchpress with free weights, multipower squat, shoulder press, armcurls and elbow extensions with dumbbells, lateral pulldown, abdominal crunches, and low back extensions.2-3 sets x 10-15 repsPatient changed to a lower disease severity class
From the presented studies, it appears that regular exercise may lead to physiological adaptations that increase oxidative and work capacity in patients with McArdle disease. A case study reported the effects of a 6-week strength training program. The results from the low weight and high repetition training program lowered the patient’s disease severity class (35). The training closely resembles aerobic training intensity, which could explain the benefits obtained from the training. Intervention specifications for McArdle disease are presented in Table 5.

Pompe disease

Combined aerobic and strength exercise

Muscle strength and functional capacity was shown to increase with moderate aerobic and strength exercise training in patients with late-onset Pompe disease receiving enzyme replacement therapy (36). Despite small sample size, the results are encouraging. Van den Berg et al evaluated the safety and efficacy of moderate endurance, strength, and core stability training (37). After 12-weeks, core stability, muscle strength in hip and shoulder, and functional capacity improved. The first week of training, two patients had elevated plasma CK levels, experienced muscle pain, and fatigue. During the second week, CK levels dropped to their normal range, and fatigue and pain diminished greatly. Both patients continued the training. This study indicates that a combination of aerobic, resistance and core stability training can be performed safely in patients with Pompe disease. However, when combining different modes of exercise, it can be challenging to determine which exercise improved which outcome. In 2007, a published paper evaluated whether the adherence to nutrition and exercise therapy could slow the deterioration of muscle function (38). Of the 34 patients included, 22 were fully compliant with nutrition and exercise therapy. Patients demonstrated a slowing of their deterioration in muscle function and some showed improvement in their Walton score. Whether continued compliance with nutrition and exercise therapy slows disease progression long term, and if nutrition and exercise therapy can minimize muscle deterioration at symptom onset should be further explored. Moderate intensity exercise appears to have an adjuvant effect on patients with Pompe disease and regular exercise is recommended. Side alternating vibration training (SAVT) is mechanical oscillation applied while standing on a vibrating platform. The oscillation is characterized by amplitude and frequency which determine the intensity of the work performed. One patient with Pompe underwent SAVT, and after 15 weeks of SAVT the patient showed an improvement in functional capacity and strength (39). The patient reported muscle soreness, stiffness, and aches in legs, twitching while at rest, cramping, and fatigue. Despite the discomfort, her level of activity did not change. The level of safety of SAVT is questionable and should be the subject for further exploration. Intervention specifications for Pompe disease are presented in Table 6.
Table 6.

A representation of exercise interventions done in Pompe disease. Number in parenthesis represents the article reference.

Exercise mode/NDurationFrequesncyIntensityImproved outcome
Cycling and StrengthN = 5(36)20 weeks3 days/week10-15 min/session (week 1-3)30 min/session (week 4-20)Week 1-3:Cycling at level 1-2Strength: ¼ squat, leg curl, knee raise, push-ups against a wall, back extensions, as well as sit ups, ¼ overhead press, elbow extensions and elbow curl50% of 1RM, 2 sets x 10 repsWeek 4-20:Cycling at level 2-450% of 1RM, 3 sets x 10 repsStrength increased and 6MWT
Cycling, strength, and core stabilityN = 23(37)12 weeks3 days/week60% of VO2max70% of 4RMOne session consisted of:5 minutes warm up15 minutes cyclingShoulder extension, flexion and abduction, elbow flexion, knee extension and flexion, hip flexion, abduction and adduction: 3 sets x 15-20 reps15 minutes cycling3 x 30 seconds: Abdominal bridge, side bridge, back bridgeClimb 4 steps, muscle, strength in shoulder abductors and hip flexors, 6MWT, rise from supine to standing, workload, VO2max, ventilatory threshold, and core stability
High-protein and low-carbohydrate nutrition and exercise therapyTreadmill and upper body ergometerN = 34 (22 complied with nutrition and exercise therapy(38)2y-10yDaily45 min/session on treadmill10-15 min/session upper body ergometerNot exceed RPE of 11–12Slowing of deterioration in muscle function
SAVTN = 1(39)15 weeksOne cycle:60 seconds vibration-on60 seconds vibration-offVibration frequency 5 Hz, progressing to 20 Hz by week 11, and continuing at 20 Hz to week 15Starting with two cycles initially, progressing to four cycles by week 11 and continuing with four cycles to week 15.Improved strength and 6MWT

Mitochondrial myopathy

The aspect of training patients with mitochondrial disease is somewhat different from other myopathies in that patients experience a metabolic bottleneck in the mitochondrial respiratory chain function. Taivassalo et al found that aerobic capacity increased with moderate intensity exercise on a treadmill. Fatigue and tolerance to daily activities also improved, and lactate concentration decreased (40). In 6 of the 10 participating patients, CK levels rose slightly, but not to a level indicating significant muscle damage. These findings are in agreement with a study examining the effects of moderate intensity cycling exercise (41). Similar findings were reported by Siciliano et al. (42) (43) showing a decreased lactate concentration, improved SF-36, and improved muscle oxidative metabolism with aerobic training. Jeppesen et al. (44) demonstrated that moderate aerobic training was safe and improved aerobic capacity. No training-induced increases in plasma CK levels were observed. Trenell et al also found beneficial effects from moderate aerobic training including improvement in functional abilities (45). Jeppesen et al. (46) investigated the effects of short- and long-term moderate home-based endurance exercise. Exercise increased oxidative capacity and peak work load. These improvements were sustained after 12 months of exercise. No training-induced CK elevation was observed and patients reported feeling a physical improvement. The effects of moderate intensity cycling and moderate intensity arm strength exercise revealed an increase in functional capacity and muscle strength (47). The training effect was also reflected as improvements in symptoms. To counteract limitations in the oxygen transport pathway, exercise seems to be a promising therapeutic avenue for persons affected by mitochondrial myopathy (48). The effects of SAVT was considered safe and patients showed some increase in muscle power (49). The presented studies indicate that moderate intensity aerobic exercise is safe and can improve physical capabilities in patients with mitochondrial myopathy. Intervention specifications for mitochondrial myopathies are presented in Table 7.
Table 7.

A representation of exercise interventions done in Mitochondrial myopathy. Number in parenthesis represents the reference.

Exercise mode/NDurationFrequencyIntensityImprovedoutcome
TreadmillN = 10(40)8 weeks3-4 days/week20-30 min/session60-80% HRmaxNot exceed 15 RPEAerobic capacity, lactate concentrations decreased,fatigue decreased, and tolerance to daily activities
CyclingN = 8(41)14 weeks49 sessionsWeek 1-7:3 days/week30 min/sessionWeek 8-144 days/week40 min/session70-80% HRmaxSF-36 and aerobic peak capacity
CyclingN = 7Control groupN = 12(42)10 weeksWeek 1-5:30 min/sessionWeek 6-10:45 min/sessionMax 70% HRmax60-70 revolution (paddling)/minMax 70% of predicted normal maximum power outputPartially reverting oxidative stress
CyclingN = 12Control group N = 4(43)10 weeksWeek 1-5:Every other day30 min/sessionWeek 6-10:Every other day45 min/sessionMax 70% HRmax60–70 revolution (paddling)/min60-70% of predicted normal maximum power outputLactate concentration andmuscle oxidative metabolism
CyclingN = 20Control groupN = 13(44)12 weeks50 sessions in total30 min/session65-75% HRmaxOxidativecapacity, VO2max, and workload
CyclingN = 10Control groupN = 10(45)12 weeks3 days/week30 min/session70-80% HRmaxMitochondrial functionand functional ability
CyclingN = 4(46)Initial: 12 weeksDeconditioning: 3-12 monthsSecond training phase: 12 months5 days/week3 days/week30 min/session70% of VO2maxOxidative capacity and workload
Cycling and strengthN = 10Control groupN = 10(47)12 weeks3 days/week60 min/session70% of peak work loadShoulder press, chest press, bicep curl50% of 1RM1 set x 10-15 reps (first two weeks)From week 3: 2 or 3 sets x 10-15 reps (according to tolerance)Oxygen uptake, work output, endurance, shuttle walking test, muscle strength, NHP, and clinical symptoms
SAVTN = 7(49)12 weeks3 days/week5-20 Hz (steady increase within 2 weeks)Week 1:5 Hz 1 min on, 1 min off, 1 min onWeek 2:10 Hz 2 min on, 1 min off, 1 min onWeek 3:15 Hz 2 min on, 1 min off, 1 min onWeek 4:20 Hz 2 min on, 1 min off, 1 min onWeek 5–12:20 Hz 2 min on, 1 min off, 2 min onSome increase in muscle force

Motor neuron diseases

Spinal and bulbar muscular atrophy (SBMA, Kennedy disease)

Moderate aerobic training was examined by Preisler et al. (50). By week 5 of the intervention three patients found it challenging to exercise for 30 minutes due to fatigue or not feeling well recovered in between training sessions. Patients did not experience any change in their daily physical activity, and one patient felt daily physical activity worsened post intervention. Fatigue level increased in seven patients and only one patient experienced improvement. A few patients did feel an increase in endurance, strength, and the distance they were able to walk, while others didn’t experience physical improvements or reported a worsening in endurance, strength, and walking distance. No CK level elevation occurred in seven of the 8 patients, one patient was asked to exercise with a lower frequency. High-intensity training improved fitness and workload in 8 patients after 8 weeks of training (51). One patient was excluded due to lack of compliance and one patient did not wish to continue for personal reasons. No rise in CK levels occurred after 8 and 16 weeks of training. Self-rated muscle fatigue, muscle pain, and activity level remained the same throughout the training period. Patients expressed an interest in HIT. High-intensity training seems to be a beneficial alternative in comparison to moderate aerobic training, likely because neuronal fatigue due to short duration of exercise is avoided. Bulbar involvement in patients with SBMA can cause dysphagia and swallowing difficulties. Effects of head lift exercises in swallowing showed an improvement in functional scores for oral dysphagia, indicating that head lifting exercise may factor into improving swallowing (52). Any clinical relevance should be integrated in the clinic with caution, considering the small sample size of the study. Shrader et al. examined the effects of functional exercise (53). The authors concluded that functional exercise is well tolerated, however, they did not find any functional changes and a modest increase in CK levels was observed. High-intensity training is recommended in patients with SBMA because it has the best efficacy and is preferred by patients. Intervention specifications for SBMA are presented in Table 8.
Table 8.

A representation of exercise interventions done in SMBA. Number in parenthesis represents the article reference.

Exercise mode/NDurationFrequencyIntensityImproved outcome
CyclingN = 8(50)12 weeksWeek 1-2:2 days/weekWeek 3-4:3 days/weekWeek 5-12:5 days/week30 min/session65-70% VO2maxWorkload and citrate synthase
CyclingN = 8(51)8 weeks of HIT and 8 weeks of self-training3 days/week2×5-min exercise periods with 1-min cyclic blocks of intermittent maximal intensityVO2max, workload, and 6MWT
Head lift(Shaker exercise)N = 6(52)6 weeks6 times a day for 6 weeksComponent 1: 1 min isometric, 1 min rest x 3Component 2: 30 seconds of isokineticFunctional scores for oral dysphagia
Functional exerciseN = 24StretchingN = 26(53)12 weeksWeek 1+2:2 days/weekWeek 3-12:3 days/weekWeeks 4-6:3 days/weekWeek 7-12:3 days/weekTrunk sit back, STS, standing squat with theraband row, standing lunge with theraband, forward reach, double limb heel raise, and wall pushupWeek 1+2:1 set x max reps at 50-70%% of 1RMWeek 3-12:1 set x max reps at 50-70%% of 1RMWeeks 4-6:2 sets x max reps at 50-70%% of 1RMWeek 7-12:3 sets x max reps at 50-70%% of 1RMNo functional changes

Spinal muscular atrophy

Effects of arm cycling in patients with SMA type II showed no adverse events during or after exercise. There was an increase in their cycling distances and durations, but no improvements were observed in Hammersmith Functional Motor Scale (HFMS) (54). Effects of home-based cycling was investigated by Madsen et al in 8 ambulatory patients with SMA type III (55). One patient discontinued the intervention due to severe fatigue and one patient due to difficulty using the cycle independently. Among the remaining patients, the authors found that the exercise was safe. However, patients reported either no change or an increase in fatigue, and no improvements in physical function. Submaximal resistance training is found to be well tolerated with some strength improvements with no study-related adverse events occurred (56).

Combined aerobic and strength

Moderate intensity cycling and strengthening exercise was well tolerated among all patients participating in a single blind randomized controlled clinical (57). The authors reported a large number of falls among the patients, potentially related to fatigue following training. Reporting of muscle soreness and low back pain was also documented. The most notable change was an increase in oxidative capacity. No harmful impact was observed on motor function, strength, and fatigue. In a recent Cochrane review the authors conclude that it is uncertain whether combined strength and aerobic exercise is beneficial or harmful in people with SMA (58). Further research is needed to understand the rather blunted response from exercise. High-intensity training could be a better exercise modality in SMA patients, as it has been shown to be in SBMA. Intervention specifications for SMA are presented in Table 9.
Table 9.

A representation of exercise interventions done in SMA. Number in parenthesis represents the article reference.

Exercise mode/NDurationFrequencyIntensityImproved outcome
Arm cycleN = 5(54)12 weeks3 days/week30 min/session60% HRmaxCycling distancesand durations
CyclingN = 6Control groupN = 9(55)12 weeks2-4 days/week (gradual increase)30 min/session65-70% of VO2max60-75% max HRAerobic capacity
Home based strength trainingN = 9(56)12 weeks3 days per week45-60 min/session2 sets x 15 repsAll participants exercised the Shoulder flexion, shoulder extension, elbow flexion, and elbow extension. Additionally, ambulatory participants exercised lower extremity muscles including the hip flexion, hip extension, and knee extensionSome improvement in upper limb strength
Home based cycling and strengtheningN = 9Control groupN = 7(57)1 month lead in period6 months - intervention12 month - all exercisedCycling5 days/week30 min/sessionStrengthening:3 days/weekExercise regimen was structuredbased on participant performance on the exercisetolerance test and strength assessmentsExercise ability increased slowly and VO2max

Conclusions

There is considerable amount of evidence indicating that moderate intensity aerobic- and strength exercise is advantageous for patients with muscle diseases, without causing harmful muscle damage. Exercise should be planned carefully and be well monitored, and should be performed within the patients’ limitations. Extreme fatigue and muscle pain, during or after exercise is indicative of negative response to exercise, and intensity and frequency should be reconsidered. In contrast, motor neuron diseases show different outcomes from exercise. Exercise has a rather blunted response in these patients. One possible explanation could be that they reach a level of fatigue quicker due to larger motor units that need to fire more frequently, which may cause a neural fatigue, which these patients experience after long-lasting exercise. In these patients, high-intensity training seems safe and may be a promising exercise method which allows the patient to train effectively. The presented studies include ambulatory patients. In recent years, a few studies have explored the effects of exercise using assisted devices. The effects of exercise using assistive devices should be further explored in very weak and non-ambulatory and wheelchair bound patients. In addition, it is imperative to set a goal for the exercise in order to obtain clinical relevance, and also determine the appropriateness of training in isolated muscle groups vs. whole-body. Future research should direct the focus on determining duration, frequency, and intensity in order to create an exercise guideline that clinicians and patients can use. One of the challenges in studying exercise in muscle and lower motor neuron diseases is that the diseases are rare and heterogeneous and one type of exercise may not work for everyone. Furthermore, it can be difficult to recruit a sufficient number of subjects for RCTs and examine the long- term effects of exercise, because of the rareness of the diseases. Lastly, quality of life and social aspects of exercise, as well as motivation and compliance needs more emphasis in trials on exercise therapy in muscle and motor neuron diseases. A representation of exercise interventions done in LGMD 2A, LGMD 2L, and LGMD 2I. Number in parenthesis represents the article reference. A representation of exercise interventions done in BMD. Number in parenthesis represents the article reference. A representation of exercise interventions done in FSHD. Number in parenthesis represents the article reference. A representation of exercise interventions done in DM. Number in parenthesis represents the article reference. A representation of exercise interventions done in McArdle disease. Number in parenthesis represents the article reference. A representation of exercise interventions done in Pompe disease. Number in parenthesis represents the article reference. A representation of exercise interventions done in Mitochondrial myopathy. Number in parenthesis represents the reference. A representation of exercise interventions done in SMBA. Number in parenthesis represents the article reference. A representation of exercise interventions done in SMA. Number in parenthesis represents the article reference.
  56 in total

1.  Anti-gravity training improves walking capacity and postural balance in patients with muscular dystrophy.

Authors:  Martin Peter Berthelsen; Edith Husu; Sofie Bouschinger Christensen; Kira Philipsen Prahm; John Vissing; Bente Rona Jensen
Journal:  Neuromuscul Disord       Date:  2014-03-12       Impact factor: 4.296

Review 2.  Adaptations to exercise training and contraction-induced muscle injury in animal models of muscular dystrophy.

Authors:  Gregory T Carter; R Ted Abresch; William M Fowler
Journal:  Am J Phys Med Rehabil       Date:  2002-11       Impact factor: 2.159

3.  Resistance training in patients with limb-girdle and becker muscular dystrophies.

Authors:  Marie-Louise Sveen; Søren P Andersen; Lina H Ingelsrud; Sarah Blichter; Niels E Olsen; Simon Jønck; Thomas O Krag; John Vissing
Journal:  Muscle Nerve       Date:  2012-11-21       Impact factor: 3.217

4.  High-intensity interval training in facioscapulohumeral muscular dystrophy type 1: a randomized clinical trial.

Authors:  Grete Andersen; Karen Heje; Astrid Emile Buch; John Vissing
Journal:  J Neurol       Date:  2017-05-03       Impact factor: 4.849

5.  Metabolic syndrome in neuromuscular disease.

Authors:  Susan Aitkens; David D Kilmer; Nancy C Wright; Megan A McCrory
Journal:  Arch Phys Med Rehabil       Date:  2005-05       Impact factor: 3.966

6.  High-intensity training in patients with spinal and bulbar muscular atrophy.

Authors:  Karen Heje; Grete Andersen; Astrid Buch; Henning Andersen; John Vissing
Journal:  J Neurol       Date:  2019-04-19       Impact factor: 4.849

7.  Contractile properties and susceptibility to exercise-induced damage of normal and mdx mouse tibialis anterior muscle.

Authors:  P Sacco; D A Jones; J R Dick; G Vrbová
Journal:  Clin Sci (Lond)       Date:  1992-02       Impact factor: 6.124

8.  Cognitive behavioural therapy with optional graded exercise therapy in patients with severe fatigue with myotonic dystrophy type 1: a multicentre, single-blind, randomised trial.

Authors:  Kees Okkersen; Cecilia Jimenez-Moreno; Stephan Wenninger; Ferroudja Daidj; Jeffrey Glennon; Sarah Cumming; Roberta Littleford; Darren G Monckton; Hanns Lochmüller; Michael Catt; Catharina G Faber; Adrian Hapca; Peter T Donnan; Gráinne Gorman; Guillaume Bassez; Benedikt Schoser; Hans Knoop; Shaun Treweek; Baziel G M van Engelen
Journal:  Lancet Neurol       Date:  2018-06-19       Impact factor: 44.182

9.  Safety and efficacy of a 6-month home-based exercise program in patients with facioscapulohumeral muscular dystrophy: A randomized controlled trial.

Authors:  Landry-Cyrille Bankolé; Guillaume Y Millet; John Temesi; Damien Bachasson; Marion Ravelojaona; Bernard Wuyam; Samuel Verges; Elodie Ponsot; Jean-Christophe Antoine; Fawzi Kadi; Léonard Féasson
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

10.  Effects of aerobic training on exercise-related oxidative stress in mitochondrial myopathies.

Authors:  Gabriele Siciliano; Costanza Simoncini; Annalisa Lo Gerfo; Daniele Orsucci; Giulia Ricci; Michelangelo Mancuso
Journal:  Neuromuscul Disord       Date:  2012-12       Impact factor: 4.296

View more
  5 in total

Review 1.  The effect of exercise on balance in patients with stroke, Parkinson, and multiple sclerosis: a systematic review and meta-analysis of clinical trials.

Authors:  Nader Salari; Aida Hayati; Mohsen Kazeminia; Adibeh Rahmani; Masoud Mohammadi; Reza Fatahian; Shamarina Shohaimi
Journal:  Neurol Sci       Date:  2021-10-28       Impact factor: 3.830

2.  A Strength Endurance Exercise Paradigm Mitigates Deficits in Hypoglossal-Tongue Axis Function, Strength, and Structure in a Rodent Model of Hypoglossal Motor Neuron Degeneration.

Authors:  Erika R Murphy; Rebecca Thompson; Kate L Osman; Chandler Haxton; Margaret Brothers; Li Lee; Kristen Warncke; Catherine L Smith; Amy N Keilholz; Ali Hamad; Mojgan Golzy; Filiz Bunyak; Lixin Ma; Nicole L Nichols; Teresa E Lever
Journal:  Front Neurosci       Date:  2022-06-30       Impact factor: 5.152

3.  Psychosocial impact of sport activity in neuromuscular disorders.

Authors:  Gian Luca Vita; Claudia Stancanelli; Stefania La Foresta; Cristina Faraone; Maria Sframeli; Amanda Ferrero; Cinzia Fattore; Rosy Galbo; Manfredi Ferraro; Giulia Ricci; Stefano Cotti Piccinelli; Silvia Pizzighello; Massimiliano Filosto; Andrea Martinuzzi; Luca Padua; Giuseppe Trimarchi; Gabriele Siciliano; Tiziana Mongini; Maria Elena Lombardo; Angela Berardinelli; Giuseppe Vita
Journal:  Neurol Sci       Date:  2020-04-04       Impact factor: 3.307

4.  Benefits and Mechanisms of Exercise Training for Knee Osteoarthritis.

Authors:  Chu-Yang Zeng; Zhen-Rong Zhang; Zhi-Ming Tang; Fu-Zhou Hua
Journal:  Front Physiol       Date:  2021-12-16       Impact factor: 4.566

5.  SAFETY AND TOLERABILITY OF STRENGTH TRAINING IN SPINAL AND BULBAR MUSCULAR ATROPHY: A CASE REPORT.

Authors:  Vincent Shieh; Cris Zampieri; Paul Stout; Galen O Joe; Angela Kokkinis; Kenneth H Fischbeck; Christopher Grunseich; Joseph A Shrader
Journal:  J Rehabil Med Clin Commun       Date:  2022-08-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.